S 1818

Official Title: A bill to significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other coun

Introduced: 2025-05-20

Passed House:

Passed Senate:

To President:

Became Law:

Categories: Health/Group Introduced Senate
A summary is in progress.

Action(s)

  • 05/20/2025 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • 05/20/2025 - Introduced in Senate

Bill Details

  • A bill to significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other coun

    Short Title

  • Senate

    Type

  • 119

    Congress Number

  • S1818-119

    Full Number

View on Congress.gov

Sponsor

Sen. Sanders, Bernard [I-VT]

Sen.